In the last trading session, 1.8 million Alector Inc (NASDAQ:ALEC) shares changed hands as the company’s beta touched 0.64. With the company’s per share price at $1.22 changed hands at $0.11 or 10.41% during last session, the market valuation stood at $121.99M. ALEC’s last price was a discount, traded about -455.74% off its 52-week high of $6.78. The share price had its 52-week low at $0.87, which suggests the last value was 28.69% up since then.
Analysts gave the Alector Inc (ALEC) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended ALEC as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Alector Inc (NASDAQ:ALEC) trade information
Instantly ALEC was in green as seen at the end of in last trading. With action 4.27%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -35.45%, with the 5-day performance at 4.27% in the green. However, in the 30-day time frame, Alector Inc (NASDAQ:ALEC) is 24.71% up.
The consensus price target for the stock as assigned by Wall Street analysts is 4, meaning bulls need an upside of 69.5% from its current market value. According to analyst projections, ALEC’s forecast low is 4 with 4 as the target high. To hit the forecast high, the stock’s price needs a -227.87% plunge from its current level, while the stock would need to soar -227.87% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 6.31%. The 2025 estimates are for Alector Inc earnings to decrease by -53.19%, but the outlook for the next 5-year period is at 8.74% per year.
ALEC Dividends
Alector Inc is expected to release its next quarterly earnings report in June.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 9.4145% or 9.1 million shares worth $41.32 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and Fidelity Select Portfolios-Biotechnology Portfolio . With 3.67 shares estimated at $4.47 million under it, the former controlled 3.67% of total outstanding shares. On the other hand, Fidelity Select Portfolios-Biotechnology Portfolio held about 3.01% of the shares, roughly 3.01 shares worth around $3.68 million.
